Joshua Warren Salvin, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Renal Replacement Therapy | 3 | 2021 | 282 | 1.170 |
Why?
|
| Heart Defects, Congenital | 13 | 2021 | 4671 | 0.830 |
Why?
|
| Cardiac Surgical Procedures | 8 | 2022 | 3627 | 0.770 |
Why?
|
| Acute Kidney Injury | 3 | 2021 | 1924 | 0.640 |
Why?
|
| Water-Electrolyte Imbalance | 1 | 2019 | 109 | 0.630 |
Why?
|
| Fontan Procedure | 8 | 2014 | 796 | 0.610 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2019 | 189 | 0.600 |
Why?
|
| Intensive Care Units, Pediatric | 6 | 2021 | 1017 | 0.580 |
Why?
|
| Extracorporeal Membrane Oxygenation | 9 | 2019 | 1462 | 0.560 |
Why?
|
| Postoperative Care | 4 | 2014 | 1468 | 0.550 |
Why?
|
| Thoracic Surgery | 1 | 2022 | 722 | 0.500 |
Why?
|
| Consensus Development Conferences as Topic | 1 | 2016 | 168 | 0.500 |
Why?
|
| Hypoplastic Left Heart Syndrome | 6 | 2023 | 594 | 0.440 |
Why?
|
| Postoperative Complications | 6 | 2019 | 15633 | 0.400 |
Why?
|
| Erythrocyte Transfusion | 2 | 2018 | 570 | 0.360 |
Why?
|
| Health Care Rationing | 1 | 2014 | 437 | 0.350 |
Why?
|
| Hospital Mortality | 5 | 2019 | 5293 | 0.340 |
Why?
|
| Pulmonary Atresia | 2 | 2012 | 159 | 0.340 |
Why?
|
| Cardiopulmonary Resuscitation | 3 | 2021 | 993 | 0.330 |
Why?
|
| Plasma Substitutes | 1 | 2008 | 57 | 0.320 |
Why?
|
| Tricuspid Valve | 2 | 2010 | 410 | 0.290 |
Why?
|
| Health Services Needs and Demand | 1 | 2014 | 1403 | 0.260 |
Why?
|
| Fetal Heart | 2 | 2006 | 281 | 0.250 |
Why?
|
| Length of Stay | 5 | 2019 | 6426 | 0.230 |
Why?
|
| Resuscitation | 1 | 2008 | 673 | 0.230 |
Why?
|
| Cardiology | 1 | 2014 | 1656 | 0.210 |
Why?
|
| Endocardial Fibroelastosis | 1 | 2023 | 56 | 0.210 |
Why?
|
| Heart Arrest | 3 | 2019 | 1514 | 0.190 |
Why?
|
| Patient Selection | 1 | 2014 | 4244 | 0.190 |
Why?
|
| Decision Making | 2 | 2023 | 3929 | 0.190 |
Why?
|
| Heart Diseases | 2 | 2012 | 2781 | 0.190 |
Why?
|
| Fetal Diseases | 2 | 2006 | 913 | 0.190 |
Why?
|
| Child | 17 | 2023 | 80158 | 0.180 |
Why?
|
| Cardiopulmonary Bypass | 2 | 2019 | 1092 | 0.170 |
Why?
|
| Critical Care | 3 | 2023 | 2697 | 0.150 |
Why?
|
| Retrospective Studies | 20 | 2022 | 80647 | 0.150 |
Why?
|
| Coronary Care Units | 2 | 2016 | 235 | 0.150 |
Why?
|
| Coronary Occlusion | 1 | 2019 | 304 | 0.130 |
Why?
|
| Mitochondria, Heart | 1 | 2017 | 229 | 0.130 |
Why?
|
| Infant | 13 | 2019 | 36193 | 0.130 |
Why?
|
| Pulmonary Artery | 3 | 2010 | 1927 | 0.130 |
Why?
|
| Child, Preschool | 13 | 2019 | 42232 | 0.120 |
Why?
|
| Risk Factors | 10 | 2022 | 74213 | 0.120 |
Why?
|
| Infant, Newborn | 12 | 2019 | 26202 | 0.120 |
Why?
|
| Brain Infarction | 2 | 2014 | 290 | 0.120 |
Why?
|
| Milrinone | 1 | 2014 | 86 | 0.110 |
Why?
|
| Ghana | 1 | 2014 | 315 | 0.100 |
Why?
|
| Hemodynamics | 5 | 2023 | 4160 | 0.100 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2016 | 774 | 0.100 |
Why?
|
| Monitoring, Physiologic | 1 | 2019 | 1779 | 0.100 |
Why?
|
| Boston | 5 | 2021 | 9327 | 0.090 |
Why?
|
| Intensive Care Units | 2 | 2023 | 3744 | 0.090 |
Why?
|
| Recovery of Function | 2 | 2014 | 2979 | 0.090 |
Why?
|
| Intracranial Hemorrhages | 2 | 2014 | 822 | 0.090 |
Why?
|
| Heart Transplantation | 2 | 2023 | 3233 | 0.090 |
Why?
|
| Blalock-Taussig Procedure | 1 | 2010 | 60 | 0.090 |
Why?
|
| Oxygen | 2 | 2019 | 4227 | 0.090 |
Why?
|
| Critical Illness | 2 | 2021 | 2723 | 0.090 |
Why?
|
| Norwood Procedures | 1 | 2012 | 192 | 0.090 |
Why?
|
| Perioperative Period | 1 | 2011 | 250 | 0.080 |
Why?
|
| Carotid Arteries | 1 | 2014 | 941 | 0.080 |
Why?
|
| Adolescent | 9 | 2021 | 88326 | 0.080 |
Why?
|
| Humans | 31 | 2023 | 761596 | 0.080 |
Why?
|
| Catheterization | 1 | 2014 | 1428 | 0.080 |
Why?
|
| Male | 20 | 2022 | 360846 | 0.080 |
Why?
|
| Survival | 1 | 2008 | 161 | 0.080 |
Why?
|
| Choice Behavior | 1 | 2014 | 825 | 0.070 |
Why?
|
| Postoperative Period | 2 | 2011 | 1814 | 0.070 |
Why?
|
| Heart Ventricles | 3 | 2023 | 3807 | 0.070 |
Why?
|
| Hemorrhage | 1 | 2018 | 3424 | 0.070 |
Why?
|
| Life Tables | 1 | 2006 | 364 | 0.070 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2016 | 2244 | 0.070 |
Why?
|
| Respiration, Artificial | 3 | 2012 | 2630 | 0.060 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2014 | 1723 | 0.060 |
Why?
|
| Vena Cava, Superior | 1 | 2006 | 195 | 0.060 |
Why?
|
| Heart Septum | 1 | 2006 | 301 | 0.060 |
Why?
|
| Female | 21 | 2019 | 392705 | 0.060 |
Why?
|
| Myocardium | 1 | 2017 | 4725 | 0.060 |
Why?
|
| Ebstein Anomaly | 1 | 2005 | 105 | 0.060 |
Why?
|
| Risk Assessment | 4 | 2019 | 23996 | 0.060 |
Why?
|
| Survival Analysis | 3 | 2012 | 10090 | 0.060 |
Why?
|
| Evidence-Based Medicine | 1 | 2016 | 3688 | 0.060 |
Why?
|
| Anthropology, Cultural | 1 | 2023 | 102 | 0.050 |
Why?
|
| Arteriovenous Shunt, Surgical | 1 | 2006 | 292 | 0.050 |
Why?
|
| Anastomosis, Surgical | 1 | 2006 | 983 | 0.050 |
Why?
|
| Cohort Studies | 5 | 2012 | 41495 | 0.050 |
Why?
|
| Ventricular Function, Left | 1 | 2014 | 3879 | 0.050 |
Why?
|
| Algorithms | 1 | 2022 | 14033 | 0.050 |
Why?
|
| Treatment Outcome | 7 | 2014 | 64685 | 0.050 |
Why?
|
| Ultrasonography, Prenatal | 2 | 2006 | 1755 | 0.050 |
Why?
|
| Seizures | 1 | 2014 | 2957 | 0.050 |
Why?
|
| Gestational Age | 2 | 2006 | 3577 | 0.040 |
Why?
|
| Brain Diseases | 1 | 2009 | 1546 | 0.040 |
Why?
|
| Time Factors | 5 | 2019 | 39969 | 0.040 |
Why?
|
| Vascular Surgical Procedures | 1 | 2008 | 1489 | 0.040 |
Why?
|
| Palliative Care | 3 | 2012 | 3598 | 0.040 |
Why?
|
| Heart Failure | 2 | 2014 | 11671 | 0.040 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2008 | 1428 | 0.040 |
Why?
|
| Aorta | 2 | 2017 | 2041 | 0.040 |
Why?
|
| Phlebotomy | 1 | 2018 | 137 | 0.040 |
Why?
|
| Myoglobin | 1 | 2017 | 159 | 0.040 |
Why?
|
| Follow-Up Studies | 5 | 2014 | 39106 | 0.040 |
Why?
|
| Forecasting | 1 | 2006 | 2928 | 0.040 |
Why?
|
| Hospitals, Pediatric | 2 | 2018 | 1860 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2011 | 12463 | 0.030 |
Why?
|
| Sus scrofa | 1 | 2017 | 428 | 0.030 |
Why?
|
| Perfusion | 1 | 2021 | 1373 | 0.030 |
Why?
|
| Spectrum Analysis, Raman | 1 | 2017 | 237 | 0.030 |
Why?
|
| Coronary Angiography | 1 | 2006 | 4471 | 0.030 |
Why?
|
| Pregnancy Outcome | 1 | 2005 | 2922 | 0.030 |
Why?
|
| United States | 2 | 2019 | 72340 | 0.030 |
Why?
|
| Qualitative Research | 1 | 2023 | 3025 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 1993 | 346 | 0.030 |
Why?
|
| Logistic Models | 3 | 2012 | 13255 | 0.030 |
Why?
|
| DiGeorge Syndrome | 1 | 1993 | 185 | 0.020 |
Why?
|
| Hemoglobins | 1 | 2017 | 1526 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2017 | 2231 | 0.020 |
Why?
|
| Proxy | 1 | 2012 | 151 | 0.020 |
Why?
|
| Cardiotonic Agents | 1 | 2014 | 539 | 0.020 |
Why?
|
| Quality of Life | 1 | 2012 | 13367 | 0.020 |
Why?
|
| Femoral Artery | 1 | 2014 | 826 | 0.020 |
Why?
|
| Medical Audit | 1 | 2011 | 453 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 2014 | 2217 | 0.020 |
Why?
|
| Disease Progression | 1 | 2006 | 13510 | 0.020 |
Why?
|
| Communication | 1 | 2023 | 3875 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2010 | 6484 | 0.020 |
Why?
|
| Chromosome Deletion | 1 | 1993 | 1386 | 0.020 |
Why?
|
| Inflammation | 1 | 2008 | 10774 | 0.020 |
Why?
|
| Echocardiography, Doppler | 1 | 2012 | 897 | 0.020 |
Why?
|
| Linear Models | 1 | 2018 | 5872 | 0.020 |
Why?
|
| Coronary Vessels | 1 | 2019 | 3096 | 0.020 |
Why?
|
| Registries | 2 | 2014 | 8225 | 0.020 |
Why?
|
| Myocardial Ischemia | 1 | 2017 | 2113 | 0.020 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2010 | 353 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2017 | 8181 | 0.020 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2010 | 576 | 0.020 |
Why?
|
| Survival Rate | 2 | 2014 | 12723 | 0.020 |
Why?
|
| Abnormalities, Multiple | 1 | 1993 | 1423 | 0.020 |
Why?
|
| Brain Death | 1 | 2009 | 357 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2012 | 3415 | 0.020 |
Why?
|
| Multivariate Analysis | 2 | 2012 | 12059 | 0.020 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2010 | 628 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2011 | 2643 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2009 | 2496 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2014 | 6312 | 0.010 |
Why?
|
| Fetal Death | 1 | 2005 | 435 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2014 | 10766 | 0.010 |
Why?
|
| Adult | 3 | 2019 | 221210 | 0.010 |
Why?
|
| Prevalence | 2 | 2014 | 15733 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2014 | 12341 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2012 | 9647 | 0.010 |
Why?
|
| Patient Discharge | 1 | 2012 | 3443 | 0.010 |
Why?
|
| Prognosis | 1 | 2019 | 29629 | 0.010 |
Why?
|
| Acute Disease | 1 | 2009 | 7237 | 0.010 |
Why?
|
| Cross-Sectional Studies | 2 | 2012 | 26129 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2021 | 54423 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2012 | 15843 | 0.010 |
Why?
|
| Age Factors | 1 | 2011 | 18399 | 0.010 |
Why?
|
| Young Adult | 1 | 2019 | 59260 | 0.010 |
Why?
|
| Echocardiography | 1 | 2005 | 4989 | 0.010 |
Why?
|
| Velopharyngeal Insufficiency | 1 | 1993 | 102 | 0.010 |
Why?
|
| Middle Aged | 2 | 2019 | 220921 | 0.010 |
Why?
|
| Genetic Counseling | 1 | 1993 | 627 | 0.010 |
Why?
|
| Pregnancy | 2 | 2005 | 29890 | 0.000 |
Why?
|
| Cleft Palate | 1 | 1993 | 589 | 0.000 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 1993 | 2510 | 0.000 |
Why?
|
| Syndrome | 1 | 1993 | 3267 | 0.000 |
Why?
|
| Incidence | 1 | 2005 | 21355 | 0.000 |
Why?
|
| Prenatal Diagnosis | 1 | 1993 | 1265 | 0.000 |
Why?
|
| Gene Deletion | 1 | 1993 | 2665 | 0.000 |
Why?
|
| Pedigree | 1 | 1993 | 4542 | 0.000 |
Why?
|
| Animals | 1 | 2017 | 168475 | 0.000 |
Why?
|
| DNA Mutational Analysis | 1 | 1993 | 4111 | 0.000 |
Why?
|
| Genetic Testing | 1 | 1993 | 3537 | 0.000 |
Why?
|